FALCONI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 11.049
EU - Europa 7.674
AS - Asia 6.640
SA - Sud America 3.434
AF - Africa 389
Continente sconosciuto - Info sul continente non disponibili 48
OC - Oceania 4
Totale 29.238
Nazione #
US - Stati Uniti d'America 10.823
BR - Brasile 2.737
VN - Vietnam 2.048
SG - Singapore 1.910
UA - Ucraina 1.666
RU - Federazione Russa 1.575
IE - Irlanda 821
DE - Germania 757
IT - Italia 663
DK - Danimarca 627
HK - Hong Kong 597
SE - Svezia 526
CN - Cina 470
TR - Turchia 453
FI - Finlandia 397
KR - Corea 328
FR - Francia 323
AR - Argentina 274
BD - Bangladesh 153
MA - Marocco 146
GB - Regno Unito 137
IN - India 131
ID - Indonesia 126
EC - Ecuador 121
IQ - Iraq 98
CO - Colombia 92
MX - Messico 88
ZA - Sudafrica 78
CA - Canada 68
PY - Paraguay 57
PK - Pakistan 54
EU - Europa 47
VE - Venezuela 45
AT - Austria 40
CL - Cile 37
PE - Perù 34
TN - Tunisia 34
CI - Costa d'Avorio 33
PH - Filippine 31
JP - Giappone 27
UY - Uruguay 26
UZ - Uzbekistan 26
EG - Egitto 24
PL - Polonia 24
DZ - Algeria 21
KE - Kenya 21
JO - Giordania 20
NL - Olanda 20
AE - Emirati Arabi Uniti 19
ES - Italia 18
KZ - Kazakistan 17
TH - Thailandia 15
AL - Albania 14
SA - Arabia Saudita 13
BE - Belgio 12
JM - Giamaica 12
BO - Bolivia 11
DO - Repubblica Dominicana 11
MY - Malesia 11
LB - Libano 10
OM - Oman 10
BY - Bielorussia 9
NP - Nepal 9
AZ - Azerbaigian 8
CR - Costa Rica 8
BG - Bulgaria 7
CZ - Repubblica Ceca 7
GT - Guatemala 7
HN - Honduras 7
RS - Serbia 7
SN - Senegal 7
AM - Armenia 6
KG - Kirghizistan 6
PA - Panama 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
IL - Israele 5
AU - Australia 4
BH - Bahrain 4
ET - Etiopia 4
GE - Georgia 4
PS - Palestinian Territory 4
RO - Romania 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
BW - Botswana 3
GN - Guinea 3
KH - Cambogia 3
KW - Kuwait 3
LT - Lituania 3
LV - Lettonia 3
PR - Porto Rico 3
BS - Bahamas 2
CG - Congo 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
IR - Iran 2
ML - Mali 2
Totale 29.210
Città #
Jacksonville 1.629
Ashburn 1.104
Fairfield 1.006
Singapore 972
Dublin 819
Ho Chi Minh City 698
Boardman 661
Hong Kong 591
Wilmington 494
Dallas 482
Hanoi 427
Woodbridge 406
Houston 383
Council Bluffs 363
Seattle 353
San Mateo 330
Lawrence 328
Princeton 328
Chandler 305
San Jose 300
Cambridge 288
Lauterbourg 285
Centro 277
Moscow 247
The Dalles 221
São Paulo 214
New York 186
Ann Arbor 164
San Diego 138
Des Moines 134
Hefei 127
Da Nang 99
Los Angeles 94
Milan 91
Beijing 90
Rio de Janeiro 86
Haiphong 83
Curitiba 56
Helsinki 55
Brasília 48
Porto Alegre 48
Chicago 46
Belo Horizonte 45
Guayaquil 42
Miano 42
Nuremberg 41
Biên Hòa 38
Quito 35
Thái Bình 34
Abidjan 33
Munich 33
Saint Petersburg 33
Salvador 33
London 32
Baghdad 31
Campinas 30
Ribeirão Preto 30
Orem 29
Hải Dương 28
Johannesburg 26
São Bernardo do Campo 24
Guarulhos 23
Phủ Lý 23
Santa Clara 23
Sorocaba 23
Tashkent 23
Thái Nguyên 23
Can Tho 22
Dhaka 22
Asunción 21
Lima 21
Ninh Bình 21
Norwalk 21
Shanghai 21
Turku 21
Brooklyn 20
Buenos Aires 20
Denver 20
Guangzhou 20
Manaus 20
Warsaw 20
Goiânia 19
Vienna 19
Amman 18
Cape Town 18
Jakarta 18
Nairobi 18
Buffalo 17
Bắc Ninh 17
Fortaleza 17
Medellín 17
Montreal 17
Santo André 17
Bogotá 16
Chennai 16
Duque de Caxias 16
Nova Iguaçu 16
Osasco 16
Salt Lake City 16
Tokyo 16
Totale 16.447
Nome #
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases. 171
Absence of mutations in the transforming growth factor-beta inducible early gene 1, TIEG1, in pancreatic cancer. 167
[Closed surgical treatment in acute severe pancreatitis] 163
A single istitution experience with fistulojejunostomy for external pancreatic fistulas 159
Adequacy of Lymph Node Retrieval for Ampullary Cancer and Its Association with Improved Staging and Survival. 154
Acoustic radiation force impulse ultrasound imaging of pancreatic cystic lesions: preliminary results 146
Acute necrotizing pancreatitis and fistula treatment: the role of somatostatin - 14 and its analogues. 146
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations. 144
Poorly differentiated resectable pancreatic cancer: Is upfront resection worthwhile? 142
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 141
Intraductal papillary mucinous neoplasms and chronic pancreatitis. 138
Alchool intake,cigarette smoking and body mass index in patients with alcohol associated pancreatitis 137
A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma. 136
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. 135
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years 135
Ultrasonography of the pancreas. 7. Intraoperative imaging. 130
Clinical and Patient-Reported Outcomes After Pancreatoduodenectomy for Different Diseases: A Follow-Up Study. 129
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. 129
Enhanced recovery pathways in pancreatic surgery: State of the art 129
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 128
Italian consensus guidelines for chronic pancreatitis 127
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 127
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 126
B-Cell Lymphoma Presenting as Acute Pancreatitis. 126
Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian association for the study of the pancreas. 125
Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11 124
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomized controlled trial 124
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal. 122
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. 121
Adenocarcinoma pancreatico umano primario ed espressione dell’ossido nitrico sintetasi inducibile e cicloossigenasi–2. 120
A preoperative score to predict early death after pancreatic cancer resection 120
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 120
Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study. 119
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 118
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. 117
A systematic review on robotic pancreaticoduodenectomy. 115
Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI. 114
Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts-A shape shifting outlook into an increasingly recognized disease. 113
Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography 113
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. 111
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside. 111
Alcohol intake, cigarette smoking, and body mass index in patients with alcohol-asociated pancreatitis 111
Role of Resection of the Primary Pancreatic Neuroendocrine Tumour Only in Patients with Unresectable Metastatic Liver Disease: A Systematic Review. 110
The role of disease causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. 109
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. 109
Neuroendocrine Tumor Disease- An Evolving Landscape. 108
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology 108
Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 106
Minimally invasive necrosectomy versus conventional surgery in the treatment of infected pancreatic necrosis: a systematic review and a meta-analysis of comparative studies. 106
Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms 106
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System. Well-Differentiated Pancreatic Non-Functioning Tumors. 104
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 104
Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis 104
Anastomotic leakage in pancreatic surgery. 104
Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. 104
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy 103
Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. 103
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. 103
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 103
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. 103
Pancreatoblastoma in adults: a review of the literature. 102
Smoking cessation at the clinical onset of chronic pancreatitis and risk of pancreatic calcifications 102
Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. 102
Allelotype of pancreatic acinar cell carcinoma. 102
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. 102
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. 102
Discussion on prophylactic antibiotic treatment in patients with predicted severe pancreatitis: a placebo-controlled, double-blind trial 101
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 101
Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma 101
Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. 101
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 101
Identification of a novel antibody associated with autoimmune pancreatitis 100
Treatment trends in metastatic pancreatic cancer patients: Is it time to change? 100
Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. 100
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors 100
Cancer Risk among the Relatives of Patients with Pancreatic Ductal Adenocarcinoma. 99
Pancreas: Insulinoma--new insights into an old disease. 99
Previous cholecystectomy, gastrectomy, and diabetes mellitus are not crucial risk factors for pancreatic cancer in patients with chronic pancreatitis 99
Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1. 99
ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors. 99
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. 99
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. 99
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries 99
Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor 98
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 98
Current status of robotic distal pancreatectomy: a systematic review. 98
Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. 97
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. 96
In vivo octreotide administration acutely reduces exocrine granule size in the human pancreas 96
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. 96
Cisti splenica epiteliale 96
Extent of surgical resections for intraductal papillary mucinous neoplasms. 96
Well-differentiated pancreatic nonfunctioning tumors/carcinoma 96
Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses 95
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 95
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms. 95
Long-term results of Frey's procedure for chronic pancreatitis: a longitudinal prospective study on 40 patients. 94
Contrast-enhanced ultrasonography in the characterization of pancreatic mucinous cystadenoma 94
Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT 94
Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression 94
Totale 11.317
Categoria #
all - tutte 145.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.216


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.074 123 565 12 93 3 179 78 149 116 209 51 496
2022/20231.886 367 189 228 61 56 120 2 32 736 3 49 43
2023/20241.386 328 7 32 349 325 145 18 9 1 8 4 160
2024/20253.651 227 535 39 9 66 21 521 105 1.113 252 299 464
2025/202611.401 498 1.145 1.202 2.765 358 451 1.719 1.136 681 815 115 516
2026/2027310 310 0 0 0 0 0 0 0 0 0 0 0
Totale 29.309